Xuezhikang Decreases Serum Lipoprotein(a) and C-reactive Protein Concentrations in Patients with Coronary Heart Disease | Zendy

Ling Liu | Zendy; ShuiPing Zhao | Zendy; Yan-Chun Cheng | Zendy; Yuling Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Xuezhikang Decreases Serum Lipoprotein(a) and C-reactive Protein Concentrations in Patients with Coronary Heart Disease

Author(s) -

Ling Liu,

ShuiPing Zhao,

Yan-Chun Cheng,

Yuling Li

Publication year - 2003

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/49.8.1347

Subject(s) - postprandial , medicine , triglyceride , endocrinology , meal , lipoprotein , c reactive protein , placebo , cholesterol , inflammation , insulin , alternative medicine , pathology

Increased serum lipoprotein(a) [Lp(a)] and high-sensitivity C-reactive protein (hsCRP) concentrations are independent risk factors for coronary heart disease (CHD). Xuezhikang, an extract of cholestin, effectively lowers fasting cholesterol and triglyceride concentrations. We studied whether xuezhikang lowered Lp(a) and hsCRP concentrations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research